4.365
14.75%
-0.755
Macrogenics Inc (MGNX) 最新ニュース
Insider Selling: Peters Jeffrey Stuart, Macrogenics Inc [MGNX] Senior VP and General Counsel divested 51395 shares ... - Knox Daily
Knox Daily
Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength? - Yahoo Lifestyle UK
Yahoo Lifestyle UK
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX - PR Newswire
PR Newswire
MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman - GlobeNewswire
GlobeNewswire
2024-05-16 | NDAQ:MGNX | Press Release | MacroGenics Inc - Stockhouse Publishing
Stockhouse Publishing
Q2 2024 EPS Estimates for MacroGenics, Inc. (NASDAQ:MGNX) Cut by HC Wainwright - Defense World
Defense World
MacroGenics Plunges On Prostate Cancer ADC Safety Concerns - Scrip
Scrip
MacroGenics, Inc. to Post Q2 2024 Earnings of ($0.70) Per Share, HC Wainwright Forecasts (NASDAQ:MGNX) - MarketBeat
MarketBeat
2024-05-15 | NDAQ:MGNX | Press Release | MacroGenics Inc - Stockhouse Publishing
Stockhouse Publishing
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics ... - GlobeNewswire
GlobeNewswire
Equities Analysts Set Expectations for MacroGenics, Inc.'s Q1 2025 Earnings (NASDAQ:MGNX) - Defense World
Defense World
MacroGenics (NASDAQ:MGNX) Price Target Cut to $4.00 - Defense World
Defense World
Why Akamai Technologies, NuVasive, and MacroGenics Jumped Today - Yahoo News UK
Yahoo News UK
MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics Stockholders and Encourages Investors to Contact the Firm - ForexTV.com
ForexTV.com
Clinical Report: MacroGenics faces ADC safety concerns - BioCentury
BioCentury
MacroGenics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Lifestyle UK
Yahoo Lifestyle UK
HC Wainwright Comments on MacroGenics, Inc.'s Q1 2025 Earnings (NASDAQ:MGNX) - MarketBeat
MarketBeat
MacroGenics, Inc. (MGNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - AccessWire
AccessWire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and ... - Morningstar
Morningstar
JMP Securities Lowers MacroGenics (NASDAQ:MGNX) Price Target to $16.00 - Defense World
Defense World
HC Wainwright Trims MacroGenics (NASDAQ:MGNX) Target Price to $4.00 - MarketBeat
MarketBeat
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX) - Business Wire
Business Wire
Brokers Are Upgrading Their Views On MacroGenics, Inc. (NASDAQ:MGNX) With These New Forecasts - Yahoo Movies UK
Yahoo Movies UK
MacroGenics (MGNX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Lifestyle UK
Yahoo Lifestyle UK
MacroGenics, Inc. (MGNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - AccessWire
AccessWire
MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswire
GlobeNewswire
MacroGenics shares target cut by H.C. Wainwright on trial safety concerns - Investing.com Canada
Investing.com Canada
MacroGenics shares target cut by H.C. Wainwright on trial safety concerns - Investing.com South Africa
Investing.com South Africa
MacroGenics, Inc.'s (NASDAQ:MGNX) 81% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St
Simply Wall St
MacroGenics to Participate in Upcoming Investor Conferences - Yahoo Finance UK
Yahoo Finance UK
MacroGenics: Strong Likelihood Bad News Has Caused Overreaction (Rating Upgrade) (MGNX) - Seeking Alpha
Seeking Alpha
MacroGenics (NASDAQ:MGNX) Price Target Cut to $14.00 - Defense World
Defense World
MacroGenics (NASDAQ:MGNX) Downgraded by TD Cowen to “Hold” - Defense World
Defense World
MacroGenics Sees Hammer Chart Pattern: Time to Buy? - Yahoo Lifestyle Australia
Yahoo Lifestyle Australia
US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results - Yahoo Finance UK
Yahoo Finance UK
StockWatch: MacroGenics Shares Crater after Trial Deaths - Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
MacroGenics (MGNX) Stock Forecast and Price Target 2024 - MarketBeat
MarketBeat
MacroGenics First Quarter 2024 Earnings: Misses Expectations - Simply Wall St
Simply Wall St
MacroGenics stock downgraded amid safety concerns - Investing.com ZA - Investing.com South Africa
Investing.com South Africa
MacroGenics stock downgraded amid safety concerns By Investing.com - Investing.com Australia
Investing.com Australia
MacroGenics stock downgraded amid safety concerns - Investing.com India
Investing.com India
MacroGenics stock downgraded amid safety concerns By Investing.com - Investing.com Canada
Investing.com Canada
Stifel Downgrades MacroGenics (MGNX) - MSN
MSN
Barclays Trims MacroGenics (NASDAQ:MGNX) Target Price to $14.00 - MarketBeat
MarketBeat
MacroGenics stock downgraded amid safety concerns By Investing.com - Investing.com UK
Investing.com UK
Macrogenics Stock Drops 77% After Study Deaths - The Wall Street Journal
The Wall Street Journal
MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman - GlobeNewswire
GlobeNewswire
Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical Developments - GuruFocus.com
GuruFocus.com
MacroGenics (NASDAQ:MGNX) Downgraded by BMO Capital Markets to Market Perform - MarketBeat
MarketBeat
MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
大文字化:
|
ボリューム (24 時間):